Works matching DE "HIGH throughput screening (Drug development)"


Results: 5
    1
    2
    3
    4
    5

    Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.929123
    By:
    • Keller, Kaylee M.;
    • Eleveld, Thomas F.;
    • Schild, Linda;
    • den Handel, Kim van;
    • den Boogaard, Marlinde van;
    • Amo-Addae, Vicky;
    • Eising, Selma;
    • Ober, Kimberley;
    • Koopmans, Bianca;
    • Looijenga, Leendert;
    • Tytgat, Godelieve A. M.;
    • Ylstra, Bauke;
    • Molenaar, Jan J.;
    • Dolman, M. Emmy M.;
    • van Hooff, Sander R.
    Publication type:
    Article